InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,126.12
(
1.22%
)
US TECH 100
17,405.20
(
1.93%
)
Dow Jones
38,669.03
(
1.16%
)
Brent Oil
83.08
(
-0.66%
)
Bitcoin
61,792.42
(
4.52%
)
Post# of 869
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

vdt

Send PM Follow Ignore
Followers 21
Posts 1779
Boards Moderated 0
Alias Born 09/11/2008

vdt

Re: None

Monday, 09/13/2021 2:24:16 PM

Monday, September 13, 2021 2:24:16 PM

Post# of 869
Target is $2.48. Based on 4 Wall Street analysts offering 12 month price targets for MTNB--Matinas BioPharma in the last 3 months. The average price target is $2.48 with a high forecast of $3.00 and a low forecast of $0.90. The average price target represents a 133.96% change from the last price of $1.06.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent MTNB News
More MTNB News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!